Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Personalised Disease Monitoring in Metastatic Breast Cancer
This ClinicalTrials.gov entry reports an active but not recruiting study evaluating personalised disease monitoring in metastatic, estrogen …
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: A Nationwide Multicenter, Single-arm, Retrospective Study of Delayed Endoscopic DTI-BR After Simple Mastectomy [NA]
A nationwide multicenter, single-arm retrospective study evaluating delayed endoscopic DTI-BR after simple mastectomy for breast cancer. The…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Lucentis Plus Tagolimumab in PD-L1+, HR+/HER2- Advanced Breast Cancer After CDK4/6 Inhibitors [Phase 2]
A Phase 2 trial evaluating Lucentis plus Tagolimumab for PD-L1-positive, HR+/HER2- advanced breast cancer after CDK4/6 inhibitors, with the …
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Immune Cell Therapy for Advanced Solid Tumors [Phase 1, Phase 2]
This is a Phase 1/2 clinical trial update for an immune cell therapy targeting advanced solid tumors, including locally advanced or metastat…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: A Short-term Preoperative, Evaluating Activity and Safety of Elacestrant Monotherapy as Compared to Elacestrant + Ovarian Function Suppression (LHRH Agonist) in Premenopausal Patients With Stage I-II ER+/HER2- Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating short-term preoperative activity and safety of elacestrant as monotherapy versus elacestrant with an LHRH …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Contrast-Free Magnetic Resonance Imaging for Breast Disease
This clinical trial update describes a contrast-free MRI approach for evaluating breast disease, sponsored by Perspectum. The study (NCT0500…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With Advanced/Metastatic HR+/HER2- Breast Cancer [Phase 2]
A Phase 2 trial is evaluating whether adding elacestrant to olaparib improves outcomes in patients with HR+/HER2- advanced or metastatic bre…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Vitamin k, D-chiro Inositol and α-lactalbumin in Bone Homeostasis
A clinical trial is evaluating the combined effects of Vitamin K, D-chiro-Inositol, and alpha-lactalbumin on bone homeostasis. The study is …
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: A Study to Determine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuvant HOrmonal Therapy for Patients With Early Breast Cancer [Phase 3]
Phase 3 clinical trial assessing a digital self-management support tool to improve quality of life for patients receiving adjuvant hormonal …
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: BRCA Mutation Carriers' Platform a Multicenter Study
A multicenter clinical trial platform for BRCA1 and BRCA2 mutation carriers is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Personalized Preventive Support for Cognitive Impairment in Non-Metastatic Breast Cancer (EFACog) [NA]
A clinical trial named EFACog investigating personalized preventive support for cognitive impairment in non-metastatic breast cancer; the st…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
A Washington University School of Medicine-sponsored clinical trial is evaluating the impact of neoadjuvant or adjuvant systemic therapy on …
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Tumor Integrating Gut Microbiota in bREast Cancer [NA]
This clinical trial update describes a study examining the relationship between gut microbiota and breast cancer, which is not yet recruitin…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: A New Tool to Promote Patient's Engagement in Their Healthcare Process
A clinical trial update describes a new tool to promote patient engagement in the healthcare process for breast cancer patients, with recrui…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases [Phase 2]
This clinical trial is evaluating Utidelone injection plus capecitabine in HER2-negative breast cancer patients with brain metastases in Pha…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer. [Phase 1]
Phase 1 trial update of Naptumomab Estafenatox in combination with durvalumab in selected advanced or metastatic solid tumors, including eso…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Study in Patients With Breast Cancer Leptomeningeal Metastasis
A Johns Hopkins study enrolling patients with leptomeningeal metastasis from breast cancer; currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Evaluation of Neoadjuvant Therapy With Trastuzumab, Pertuzumab, Docetaxel, and QL1706 in Early or Locally Advanced HER2+ Breast Cancer [Phase 2]
Phase 2 neoadjuvant trial evaluating a quadruple regimen of trastuzumab, pertuzumab, docetaxel, and QL1706 in patients with early or locally…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Combined Chemo-immunotherapy Plus SBRT in Neoadjuvant Treatment for Luminal Subtype Breast Cancer [Phase 2]
Phase 2 trial evaluating combined chemo-immunotherapy plus SBRT as neoadjuvant treatment for luminal (HR+/HER2-) breast cancer; currently no…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases [NA]
This clinical trial update describes an ongoing study evaluating standard treatment with or without SBRT for solid tumors that have 1 to 5 b…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A Study of YL202 in Selected Patients With Advanced Solid Tumors [Phase 2]
Phase 2 study of YL202 in selected patients with advanced solid tumors including non-small cell lung cancer, breast cancer, and head and nec…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Chemosensitivity During Phases of the Menstrual Cycle in Breast Cancer Patients [NA]
A recruiting clinical study at The Netherlands Cancer Institute is examining how chemosensitivity in breast cancer patients varies across ph…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Motiva Flora® Aesthetic Breast Recon® Clinical Study [NA]
The Motiva Flora Aesthetic Breast Recon trial (NCT06146231) is currently recruiting to evaluate reconstruction options for patients undergoi…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A Study of CEA-Targeted CAR-T Therapy in Patients With CEA-Positive Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial of a carcinoembryonic antigen (CEA)-targeted CAR-T therapy in patients with CEA-positive advanced solid tumors, inc…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Study Comparing EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer [Phase 3]
A Phase 3 clinical trial comparing EC-T versus PCb as adjuvant chemotherapy for non-triple-negative breast cancer; the study is currently ac…